Ilinca A, Kristoffersson U, Soller M, Lindgren AG. Familial aggregation of stroke amongst young patients in Lund Stroke Register. Eur J Neurol. 2016;23:4017.<\/p>\n
Article Google Scholar <\/p>\n
Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 2005;36:13837.<\/p>\n
Article Google Scholar <\/p>\n
Ilinca A, Samuelsson S, Piccinelli P, Soller M, Kristoffersson U, Lindgren AG. A stroke gene panel for whole-exome sequencing. Eur J Hum Genet. 2019;27:31724.<\/p>\n
Article Google Scholar <\/p>\n
Gorcenco S, Ilinca A, Almasoudi W, Kafantari E, Lindgren AG, Puschmann A. New generation genetic testing entering the clinic. Parkinsonism Relat Disord. 2020;73:7284.<\/p>\n
Article Google Scholar <\/p>\n
Fang F, Xu Z, Suo Y, Wang H, Cheng S, Li H, et al. Gene panel for Mendelian strokes. Stroke Vasc Neurol. 2020;5:41621.<\/p>\n
Article Google Scholar <\/p>\n
Ilinca A, Martinez-Majander N, Samuelsson S, Piccinelli P, Truv K, Cole J, et al. Whole-Exome sequencing in 22 Young Ischemic stroke patients with familial clustering of stroke. Stroke 2020;51:105663.<\/p>\n
Article Google Scholar <\/p>\n
Ilinca A, Englund E, Samuelsson S, Truv K, Kafantari E, Martinez-Majander N, et al. MAP3K6 mutations in a neurovascular disease causing stroke, cognitive impairment, and tremor. Neurol Genet. 2021;7:e548.<\/p>\n
Article Google Scholar <\/p>\n
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). Online Mendelian Inheritance in Man, 2022. https:\/\/omim.org\/<\/a>.<\/p>\n Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke; 24:3541.<\/p>\n Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, et al. A computerized algorithm for etiologic classification of ischemic stroke: The Causative Classification of Stroke system. Stroke 2007;38:297984.<\/p>\n Article Google Scholar <\/p>\n Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, et al. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am J Hum Genet. 2017;100:895906.<\/p>\n Article Google Scholar <\/p>\n Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:40524.<\/p>\n Article Google Scholar <\/p>\n Won D, Kim SH, Kim B, Lee ST, Kang HC, Choi JR. Reanalysis of genomic sequencing results in a clinical laboratory: advantages and limitations. Front Neurol. 2020;11:612.<\/p>\n Article Google Scholar <\/p>\n Matalonga L, Hernndez-Ferrer C, Piscia D, Solve-RD SNV-indel working group, Schle R, Synofzik M, et al. Solving patients with rare diseases through programmatic reanalysis of genome-phenome data. Eur J Hum Genet. 2021;29:133747.<\/p>\n Article Google Scholar <\/p>\n Gannamani R, van der Veen S, van Egmond M, de Koning TJ, Tijssen MAJ. Challenges in clinicogenetic correlations: one phenotype - many genes. Mov Disord Clin Pr. 2021;8:31121.<\/p>\n Article Google Scholar <\/p>\n Hyakuna N, Muramatsu H, Higa T, Chinen Y, Wang X, Kojima S. Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome-like disorder. Pediatr Blood Cancer. 2015;62:5424.<\/p>\n Article Google Scholar <\/p>\n Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, et al. DIAPH1 variants in Non-East Asian patients with sporadic moyamoya disease. JAMA Neurol. 2021;78:9931003.<\/p>\n Article Google Scholar <\/p>\n Pinard A, Guey S, Guo D, Cecchi AC, Kharas N, Wallace S, et al. The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2020;22:42731.<\/p>\n Article Google Scholar <\/p>\n Angione K, Gibbons M, Demarest S. An objective method for evaluating next-generation sequencing panels. J Child Neurol. 2019;34:13943.<\/p>\n Article Google Scholar <\/p>\n Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E, et al. ClinGen Resource. Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGens Actionability Working Group. Hum Mutat. 2018;39:167785. https:\/\/search.clinicalgenome.org\/kb\/genes\/HGNC:3603<\/a>.<\/p>\n Article Google Scholar <\/p>\n <\/p>\n See original here: Ilinca A, Kristoffersson U, Soller M, Lindgren AG. Familial aggregation of stroke amongst young patients in Lund Stroke Register. Eur J Neurol. Continue reading
\nUpdated Stroke Gene Panels: Rapid evolution of knowledge on monogenic causes of stroke | European Journal of Human Genetics - Nature.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"